Sharon Wrobel

About the Author Sharon Wrobel


AstraZeneca’s Covid-19 Trial Slated To Resume This Week – Report

AstraZeneca’s US Covid-19 vaccine trial is poised to resume as early as this week after the US Food and Drug Administration completed its …

iRobot Sales Surge 43% Fueled By Roomba Vacuum Online Sales

iRobot quarterly sales jumped 43% blowing past the Street consensus as consumers stocked up on its robot vacuum cleaners during the coronavirus pandemic. …

AMC Dives 13% On Share Sale, Liquidity Warning

Shares in AMC Entertainment are sinking 13% after the cash-strapped theater chain announced plans to sell another 15 million shares in a public offering …

Activist Investor Starboard Ramps Up ACI Stake To 9%; Shares Rise

Activist investor Starboard Value ramped up its stake in ACI Worldwide to 9% sending shares in the payment systems software provider up about …

UBS Rises As Quarterly Profit Pops 99%; Street Sees 22% Upside

Shares in UBS are soaring 6% as the Swiss bank’s quarterly profit jumped 99% fueled by “strong” client activity in global stock markets. …

Verizon Nabs Microsoft, Nokia For Private 5G Networks

Verizon has teamed up with Microsoft Corp. and Nokia to help its business clients globally to build faster and more secure applications through …

Tesla 3Q California Car Registrations Slip 13% – Report

Tesla’s vehicle registrations recorded in California, its largest US market, suffered a 13% decline in the third quarter versus the same period last …

Logitech Ramps Up 2021 Outlook As 2Q Sales Pop 75%

Logitech’s quarterly revenue soared 75% as the computer products maker continued to profit from the work-at-home shift exacerbated by the coronavirus pandemic. Logitech’s …

ConocoPhillips Snaps Up Rival Concho in $9.7B Deal; Shares Advance

Shares in ConocoPhillips are advancing 2.7% in Monday’s pre-market session after the oil producer announced the $9.

AstraZeneca Gets EU Recommendations For Heart Failure, Lung Treatments

AstraZeneca announced on Monday that the European Medicines Agency (EMA) has put forward recommendations to approve Forxiga, its treatment of symptomatic chronic heart …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts